Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Preclinical Development: Overview01:28

Preclinical Development: Overview

5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

269
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
269
Drug Regulation01:25

Drug Regulation

2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A Pseudolenticular Fibrin Membrane in Recurrent Hypopyon Uveitis.

American journal of ophthalmology·2026
Same author

Medicinal Chemistry Perspectives on Drug Repurposing: Innovative Approaches and Therapeutic Breakthrough.

Therapeutic innovation & regulatory science·2026
Same author

Coumarin-based small molecules for diabetes management: rational design, computational studies, synthesis, and biological evaluation.

Journal of computer-aided molecular design·2026
Same author

Ultrasonographic Findings in Periarthritis of the Shoulder and Their Correlation With Clinical Severity.

Cureus·2026
Same author

Corrigendum to "Demethyleneberberine attenuates combined cognitive and metabolic dysfunctions in an insulin-resistance-induced Alzheimer's disease rat model: Synthesis, in-silico and in-vivo insights" [Experimental Neurology, 398 (2026) 115634].

Experimental neurology·2026
Same author

Modulation of the AMPK/TFEB Axis by Ezetimibe Attenuates Neuroinflammatory, Oxidative Stress, and Neurotransmitter Dysregulation in Naloxone-precipitated Tramadol Withdrawal in Mice.

Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology·2026

相关实验视频

Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K

药物开发 药物开发

Pragati Silakari1, Aditi Yadav1, Poonam Piplani2

  • 1Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab, India.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
PubMed
概括

一种新型化合物P-1显示出强大的选择性乙胆酶 (AChE) 抑制和抗氧化活性,有效地恢复阿尔茨海默氏症患者的记忆力.

科学领域:

  • 药用化学和药理学 医学化学和药理学
  • 神经科学和神经退行性疾病

背景情况:

  • 阿尔茨海默病 (AD) 的特点是认知能力下降,部分原因是胆固醇系统功能障碍和氧化应激.
  • 针对乙胆酶 (AChE) 和具有抗氧化特性的新型治疗策略对于管理AD至关重要.
  • 合成的化合物2,5-Bis(4-phenethylpiperazin-1-yl)-1,4-benzoquinone (P-1) 被研究其在阿尔茨海默病治疗中的潜力.

研究的目的:

  • 为了合成和描述一种新的诺基衍生物,P-1.
  • 评估P-1的体外和体外乙胆酶 (AChE) 和丁胆酶 (BChE) 抑制潜力.
  • 在痴呆症动物模型中评估P-1的抗氧化能力和恢复记忆的效果.

主要方法:

  • 合成和P-1的光谱表征.
  • 在体外酶抑制试验 (AChE,BChE) 和抗氧化剂试验 (DPPH,H2O2清理).
  • 在小鼠体内使用斯科波胺诱导痴呆模式的体内行为研究,评估记忆和认知功能,以及体外ACHE抑制和氧化应激标记分析.

主要成果:

  • P-1 证明了选择性的 AChE 抑制 (IC50: 8.055 μM),具有高选择性指数 (1.067) 和显著的抗氧化能力.
  • 行为研究表明,在接受斯科波胺治疗的小鼠中,P-1恢复了记忆,与ex vivo AChE抑制和对接结果一致.

更多相关视频

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.3K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

446

相关实验视频

Last Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K
In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.3K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

446
  • 生物化学分析表明,P-1通过调节脂质过氧化,谷氨,甲基酶和超氧化物脱酶水平,减轻了斯科波拉胺诱导的氧化损伤.

    • 结论:

    • 合成的化合物P-1在痴呆症模型中表现出有希望的记忆恢复效果.
    • 这些效应可能是由强大的,选择性的ACHE抑制和显著的抗氧化活性介导的.
    • P-1代表了一种潜在的化合物,用于开发针对阿尔茨海默氏症的新疗法.